Conference
The impact of dose intensity on the efficacy of gemcitabine plus carboplatin (GC) therapy for recurrent platinum-sensitive ovarian cancer (PSOC): A retrospective analysis of AGO-OVAR 2.5.
Authors
Kurzeder C; Zhao L; Eisenhauer EA; Vergote IB; Du Bois A; Tai D; Wang Y; Gill JF; Hirte HW; Richter B
Volume
29
Pagination
pp. 5088-5088
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2011
DOI
10.1200/jco.2011.29.15_suppl.5088
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X